ACI
LKFT

AMP Capital Investors’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

AMP Capital Investors’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-2,400
Closed -$266K – 1143
2018
Q3 		$266K Hold
2,400
– – ﹤0.01% 1097
2018
Q2 		$221K Buy
+2,400
New +$233K ﹤0.01% 1126

Other funds holding LKFT

Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

AMP Capital Investors's LKFT Position: Q4 2018 in Review

AMP Capital Investors sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q4 2018, closing a stake of 2,400 shares — an estimated $266K sold.

AMP Capital Investors first reported a position in LKFT in Q2 2018 and held it in 2 quarters. The position peaked at $266K in Q3 2018. 85 funds tracked by Wall St. Rank hold LKFT as of Q4 2018.

  • AMP Capital Investors reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q4 2018 after selling out during the quarter.
  • AMP Capital Investors sold 2,400 Lakefront Biotherapeutics American Depositary Shares shares in Q4 2018, an estimated $266K.
  • AMP Capital Investors first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2018 and held it in 2 quarters.
  • AMP Capital Investors's Lakefront Biotherapeutics American Depositary Shares position peaked at $266K in Q3 2018.
  • 85 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q4 2018.

Based on AMP Capital Investors's 13F filing for Q4 2018, filed 13 Feb 2019.